Seroprevalence of HTLV-1/2 infection among native and immigrant pregnant women in Spain

HTLV-1=2 antenatal screening is not mandatory in European countries. The rapid increase in immigrants coming from areas endemic for HTLV-1 infection has compelled a review of this policy in Spain. From February 2006 to December 2007, a cross-sectional study was carried out in all pregnant women attended at 10 different Spanish hospitals. An enzyme immunoassay (EIA) was used to test serum HTLV-1=2 antibodies; reactive samples were further confirmed by Western blot and=or polymerase chain reaction. A total of 20,518 pregnant women were examined, of whom 18,266 (89%) were native Spaniards. Overall, 946 (4.6%) of the immigrants came from HTLV-1 endemic areas (mainly Central and South America and sub-Saharan Africa). Four samples were EIA seroreactive for HTLV-1=2, two of them in women infected with HTLV-1 coming from endemic areas. The other two women were infected with HTLV-2; one was an immigrant from Bolivia and another was a native Spaniard who admitted prior injection drug use and was HIV-1 positive. The overall HTLV-1=2 seroprevalence was 0.19 per 1000 (95% CI: 0.05-0.49=1000). For HTLV-1, the seroprevalence was 2.11 per 1000 (95% CI: 0.26-7.62=1000) in pregnant women from endemic areas. The seroprevalence of HTLV-1=2 infection is below 0.02% among pregnant women in Spain, and therefore universal screening for HTLV-1=2 infection in antenatal clinics is not warranted. However, HTLV-1=2 screening could be considered in pregnant women coming from endemic areas, in whom the rate of infection is nearly 1000-fold higher than in native Spaniards and are the only group infected with the more pathogenic HTLV-1.

Medienart:

E-Artikel

Erscheinungsjahr:

2009

Erschienen:

2009

Enthalten in:

Zur Gesamtaufnahme - volume:25

Enthalten in:

AIDS research and human retroviruses - 25(2009), 6 vom: 18. Juni, Seite 551-4

Sprache:

Englisch

Beteiligte Personen:

Treviño, Ana [VerfasserIn]
Aguilera, Antonio [VerfasserIn]
Caballero, Estrella [VerfasserIn]
Toro, Carlos [VerfasserIn]
Eiros, José M [VerfasserIn]
Ortiz de Lejarazu, Raúl [VerfasserIn]
Rodríguez-Calviño, Juan J [VerfasserIn]
Tuset, Concepción [VerfasserIn]
Gómez-Hernando, César [VerfasserIn]
Rodríguez-Iglesias, Manuel [VerfasserIn]
Ramos, José Manuel [VerfasserIn]
Rodríguez-Díaz, Juan C [VerfasserIn]
Benito, Rafael [VerfasserIn]
Trigo, Matilde [VerfasserIn]
García-Campello, Marta [VerfasserIn]
Calderón, Enrique [VerfasserIn]
Garcia, Juan [VerfasserIn]
Rodríguez, Carmen [VerfasserIn]
Soriano, Vincent [VerfasserIn]

Themen:

Antibodies, Viral
Journal Article
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 28.07.2009

Date Revised 11.11.2019

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM189456477